These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9191533)

  • 1. Association between human cancer and two polymorphisms occurring together in the p21Waf1/Cip1 cyclin-dependent kinase inhibitor gene.
    Facher EA; Becich MJ; Deka A; Law JC
    Cancer; 1997 Jun; 79(12):2424-9. PubMed ID: 9191533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between polymorphism in p21(Waf1/Cip1) cyclin-dependent kinase inhibitor gene and human oral cancer.
    Ralhan R; Agarwal S; Mathur M; Wasylyk B; Srivastava A
    Clin Cancer Res; 2000 Jun; 6(6):2440-7. PubMed ID: 10873097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium.
    Lukas J; Groshen S; Saffari B; Niu N; Reles A; Wen WH; Felix J; Jones LA; Hall FL; Press MF
    Am J Pathol; 1997 Jan; 150(1):167-75. PubMed ID: 9006333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of gene deletion of p21 (WAF1/CIP1), a cyclin-dependent protein kinase inhibitor, in thyroid carcinomas.
    Shi Y; Zou M; Farid NR; al-Sedairy ST
    Br J Cancer; 1996 Nov; 74(9):1336-41. PubMed ID: 8912526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple polymorphisms, but no mutations, in the WAF1/CIP1 gene in human brain tumours.
    Koopmann J; Maintz D; Schild S; Schramm J; Louis DN; Wiestler OD; von Deimling A
    Br J Cancer; 1995 Nov; 72(5):1230-3. PubMed ID: 7577473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the chemosensitivity of head and neck cancer cells based on the diverse function of mutated-p53.
    Shinagawa Y; Kawamata H; Omotehara F; Nakashiro K; Hoque MO; Furihata T; Horiuchi H; Imai Y; Fujimori T; Fujibayashi T
    Int J Oncol; 2003 Feb; 22(2):383-9. PubMed ID: 12527938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of evidence of association of p21WAF1/CIP1 polymorphism with lung cancer susceptibility and prognosis in Taiwan.
    Shih CM; Lin PT; Wang HC; Huang WC; Wang YC
    Jpn J Cancer Res; 2000 Jan; 91(1):9-15. PubMed ID: 10744039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic mutations of the WAF1/CIP1 gene in primary prostate cancer.
    Gao X; Chen YQ; Wu N; Grignon DJ; Sakr W; Porter AT; Honn KV
    Oncogene; 1995 Oct; 11(7):1395-8. PubMed ID: 7478562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced messenger RNA expression level of p21 CIP1 in human colorectal carcinoma tissues and its association with p53 gene mutation.
    Matsushita K; Kobayashi S; Kato M; Itoh Y; Okuyama K; Sakiyama S; Isono K
    Int J Cancer; 1996 Aug; 69(4):259-64. PubMed ID: 8797864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p21WAF1/CIP1 gene DNA sequencing and its expression in human osteosarcoma.
    Liao WM; Zhang CL; Li FB; Zeng BF; Zeng YX
    Chin Med J (Engl); 2004 Jun; 117(6):936-40. PubMed ID: 15198903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of p21WAF1/CIP1 in primary bladder tumors.
    Lacombe L; Orlow I; Silver D; Gerald WL; Fair WR; Reuter VE; Cordon-Cardo C
    Oncol Res; 1996; 8(10-11):409-14. PubMed ID: 9114433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms and probable lack of mutation in the WAF1-CIP1 gene in colorectal cancer.
    Li YJ; Laurent-Puig P; Salmon RJ; Thomas G; Hamelin R
    Oncogene; 1995 Feb; 10(3):599-601. PubMed ID: 7845685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of p21 WAF1/CIP1 protein in colorectal cancers: study of its relation to p53 mutation and Ki67 antigen expression].
    Chapusot C; Assem M; Martin L; Chalabreyssse L; Benhamiche AM; Lignier MA; Chauffert B; Teyssier JR; Faivre J; Piard F
    Pathol Biol (Paris); 2001 Mar; 49(2):115-23. PubMed ID: 11317955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p21 Waf1/Cip1 polymorphisms and risk of esophageal cancer.
    Yang W; Qi Q; Zhang H; Xu W; Chen Z; Wang L; Wang Y; Dong X; Jiao H; Huo Z
    Ann Surg Oncol; 2010 May; 17(5):1453-8. PubMed ID: 20112071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the K-ras and p53 pathways in X-ray-induced lung tumors in the rat.
    Belinsky SA; Middleton SK; Picksley SM; Hahn FF; Nikula KJ
    Radiat Res; 1996 Apr; 145(4):449-56. PubMed ID: 8600505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered topographic expression of p21WAF1/CIP1/SDI1, bcl2 and p53 during gastric carcinogenesis.
    Cho JH; Kim WH
    Pathol Res Pract; 1998; 194(5):309-17. PubMed ID: 9651943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel polymorphism in p21(waf1/cip1) cyclin dependent kinase inhibitor gene: association with human esophageal cancer.
    Bahl R; Arora S; Nath N; Mathur M; Shukla NK; Ralhan R
    Oncogene; 2000 Jan; 19(3):323-8. PubMed ID: 10656678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A protective role for common p21WAF1/Cip1 polymorphisms in human ovarian cancer.
    Milner BJ; Brown I; Gabra H; Kitchener HC; Parkin DE; Haites NE
    Int J Oncol; 1999 Jul; 15(1):117-9. PubMed ID: 10375603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of p53 and p21WAF1/CIP1 proteins in gastric and esophageal cancers: comparison with mutations of the p53 gene.
    Seta T; Imazeki F; Yokosuka O; Saisho H; Suzuki T; Koide Y; Isono K
    Dig Dis Sci; 1998 Feb; 43(2):279-89. PubMed ID: 9512119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.